BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 70930)

  • 1. Photochemotherapy of psoriasis with relevance to 8-methoxypsoralen plasma level and low intensity irradiation.
    Thune P; Volden G
    Acta Derm Venereol; 1977; 57(4):351-5. PubMed ID: 70930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical experience with the 8-methoxypsoralen-UVA therapy (photochemotherapy) of psoriasis].
    Hofmann C; Plewig G; Braun-Falco O
    Hautarzt; 1976 Dec; 27(12):588-94. PubMed ID: 1010746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of resistant psoriasis with oral 8-methoxypsoralen and longwave ultraviolet light (PUVA). A treatment schedule and a follow-up study.
    Weismann K; Howitz J; Bro-Jorgensen A
    Acta Derm Venereol; 1977; 57(1):73-6. PubMed ID: 74173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sister chromatid exchanges in lymphocytes from psoriasis patients treated with 8-methoxypsoralen and longwave ultraviolet light.
    Lambert B; Morad M; Bredberg A; Swanbeck G; Thyresson-Hök M
    Acta Derm Venereol; 1978; 58(1):13-6. PubMed ID: 75629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of 8-methoxypsoralen kinetics: a relevant factor in the treatment of psoriasis by psoralen plus ultraviolet A therapy.
    Bonnot D; Béani JC; Boitard M; Reymond JL; Bériel H; Amblard P
    Photodermatol Photoimmunol Photomed; 1994 Feb; 10(1):33-7. PubMed ID: 8180098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of 8-methoxypsoralen and phototoxicity studies during PUVA treatment of psoriasis with meladinin tablets.
    Thune P
    Acta Derm Venereol; 1978; 58(2):149-51. PubMed ID: 76395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Technical experience with 8-methoxypsoralen photochemotherapy in common psoriasis].
    Hofmann C; Plewig G; Braun-Falco O
    Hautarzt; 1976 Jun; 27(6):277-85. PubMed ID: 950302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photochemotherapy for psoriasis with orally administered methoxsalen.
    Wolff KW; Fitzpatrick TB; Parrish JA; Gschnait F; Gilchrest B; Hönigsmann H; Pathak MA; Tannenbaum L
    Arch Dermatol; 1976 Jul; 112(7):943-50. PubMed ID: 820269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 8-MOP PUVA for psoriasis: a comparison of a minimal phototoxic dose-based regimen with a skin-type approach.
    Collins P; Wainwright NJ; Amorim I; Lakshmipathi T; Ferguson J
    Br J Dermatol; 1996 Aug; 135(2):248-54. PubMed ID: 8881668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the dose-response relationship for psoralen-UVA erythema and UVB erythema.
    Cox NH; Farr PM; Diffey BL
    Arch Dermatol; 1989 Dec; 125(12):1653-7. PubMed ID: 2589859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photochemotherapy (PUVA) and psoriasis: comparison of 8-MOP and 8-MOP/5-MOP.
    Langner A; Wolska H; Kowalski J; Duralska H; Murawska E
    Int J Dermatol; 1976 Nov; 15(9):688-9. PubMed ID: 977210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of time-dependent response to psoralen plus UVA (PUVA) treatment with topical 8-methoxypsoralen (8-MOP) gel in palmoplantar dermatoses.
    Engin B; Oguz O
    Int J Dermatol; 2005 Apr; 44(4):337-9. PubMed ID: 15811091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in 8-methoxypsoralen profiles during long-term psoralen plus ultraviolet A therapy and correlations between serum 8-methoxypsoralen levels and chromametric parameters.
    Marrakchi S; Decloquement L; Pollet P; Briand G; Loesche C; Bocquet JL; Degand P; Thomas P
    Photodermatol Photoimmunol Photomed; 1991 Oct; 8(5):206-11. PubMed ID: 1822684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Photochemotherapy of psoriasis: clinical experiences with 152 patients (author's transl)].
    Wolff K; Hönigsmann H; Gschnait F; Konrad K
    Dtsch Med Wochenschr; 1975 Nov; 100(48):2471-7, 1497. PubMed ID: 1201723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of retinoids on the bioavailability of methoxy-8-psoralen].
    Beani JC; Bonnot D; Berthod F; Boitard M; Reymond JL; Beriel H; Amblard P
    Ann Dermatol Venereol; 1991; 118(4):273-5. PubMed ID: 2069337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photochemotherapy of psoriasis (PUVA) without specialized equipment.
    Petrozzi JW; Kligman AM
    Arch Dermatol; 1978 Mar; 114(3):387-90. PubMed ID: 629574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of psoralen and ultraviolet A on platelet functioning: an in vitro and in vivo study.
    Procaccini EM; Pandolfi G; Monfrecola G; Rotoli B
    Photodermatol Photoimmunol Photomed; 1992 Feb; 9(1):4-7. PubMed ID: 1390123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of 8-methoxypsoralen 2 hours after oral administration.
    Steiner I; Prey T; Gschnait F; Washüttl J; Greiter F
    Acta Derm Venereol; 1978; 58(2):185-8. PubMed ID: 76402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PUVA therapy for photosensitive psoriasis.
    Ros AM; Wennersten G
    Acta Derm Venereol; 1987; 67(6):501-5. PubMed ID: 2451375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
    Wackernagel A; Hofer A; Legat F; Kerl H; Wolf P
    Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.